Correlation Between Basilea Pharmaceutica and Straumann Holding
Can any of the company-specific risk be diversified away by investing in both Basilea Pharmaceutica and Straumann Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Basilea Pharmaceutica and Straumann Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Basilea Pharmaceutica AG and Straumann Holding AG, you can compare the effects of market volatilities on Basilea Pharmaceutica and Straumann Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Basilea Pharmaceutica with a short position of Straumann Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Basilea Pharmaceutica and Straumann Holding.
Diversification Opportunities for Basilea Pharmaceutica and Straumann Holding
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Basilea and Straumann is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Basilea Pharmaceutica AG and Straumann Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Straumann Holding and Basilea Pharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Basilea Pharmaceutica AG are associated (or correlated) with Straumann Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Straumann Holding has no effect on the direction of Basilea Pharmaceutica i.e., Basilea Pharmaceutica and Straumann Holding go up and down completely randomly.
Pair Corralation between Basilea Pharmaceutica and Straumann Holding
Assuming the 90 days trading horizon Basilea Pharmaceutica AG is expected to generate 0.49 times more return on investment than Straumann Holding. However, Basilea Pharmaceutica AG is 2.02 times less risky than Straumann Holding. It trades about -0.22 of its potential returns per unit of risk. Straumann Holding AG is currently generating about -0.24 per unit of risk. If you would invest 4,455 in Basilea Pharmaceutica AG on August 28, 2024 and sell it today you would lose (245.00) from holding Basilea Pharmaceutica AG or give up 5.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Basilea Pharmaceutica AG vs. Straumann Holding AG
Performance |
| Timeline |
| Basilea Pharmaceutica |
| Straumann Holding |
Basilea Pharmaceutica and Straumann Holding Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Basilea Pharmaceutica and Straumann Holding
The main advantage of trading using opposite Basilea Pharmaceutica and Straumann Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Basilea Pharmaceutica position performs unexpectedly, Straumann Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Straumann Holding will offset losses from the drop in Straumann Holding's long position.| Basilea Pharmaceutica vs. Santhera Pharmaceuticals Holding | Basilea Pharmaceutica vs. Idorsia | Basilea Pharmaceutica vs. Molecular Partners AG | Basilea Pharmaceutica vs. Evolva Holding SA |
| Straumann Holding vs. Sika AG | Straumann Holding vs. Lonza Group AG | Straumann Holding vs. Givaudan SA | Straumann Holding vs. Partners Group Holding |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |